Stimulant treatment profiles predicting co-occurring substance use disorders in individuals with attention-deficit/hyperactivity disorder
Open Access
- 5 February 2019
- journal article
- research article
- Published by Springer Nature in European Child & Adolescent Psychiatry
- Vol. 28 (9) , 1213-1222
Abstract
Adolescents with attention-deficit/hyperactivity disorder (ADHD) are at increased risk of developing substance use disorders (SUDs) and nicotine dependence (ND). It remains unclear whether and how stimulant treatment may affect this risk. We aimed to investigate how stimulant use profiles influence the risk of SUDs and ND, using a novel data-driven community detection analysis to construct different stimulant use profiles. Comprehensive lifetime stimulant prescription data and data on SUDs and ND were available for 303 subjects with ADHD and 219 controls, with a mean age 16.3 years. Community detection was used to define subgroups based on multiple indicators of treatment history, start age, treatment duration, total dose, maximum dose, variability, stop age. In stimulant-treated participants, three subgroups with distinct medication trajectories were distinguished (late-and-moderately dosed, n = 91; early-and-moderately dosed, n = 51; early-and-intensely dosed, n = 103). Compared to stimulant-naïve participants (n = 58), the early-and-intense treatment group had a significantly lower risk of SUDs and ND (HR = 0.28, and HR = 0.29, respectively), while the early-and-moderate group had a significantly lower risk of ND only (HR = 0.30). The late-and-moderate group was at a significantly higher risk of ND compared to the other two treatment groups (HR = 2.66 for early-and-moderate, HR = 2.78 for early-and-intense). Our findings show that in stimulant-treated adolescents with ADHD, long-term outcomes are associated with treatment characteristics, something that is often ignored when treated individuals are compared to untreated individuals.Keywords
Funding Information
- Foundation for the National Institutes of Health (R01MH62873)
- Netherlands Organization for Scientific Research (1750102007010)
- ZonMw (113202005)
This publication has 28 references indexed in Scilit:
- Stimulant Treatment of ADHD and Cigarette Smoking: A Meta-AnalysisPediatrics, 2014
- Substance use disorders in association with attention-deficit/hyperactivity disorder, co-morbid mental disorders, and medication in a nationwide sampleEuropean Neuropsychopharmacology, 2014
- ADHD, stimulant treatment in childhood and subsequent substance abuse in adulthood — A naturalistic long-term follow-up studyAddictive Behaviors, 2014
- Stimulant Medication and Substance Use OutcomesJAMA Psychiatry, 2013
- Substance use disorders in adolescents with attention deficit hyperactivity disorder: a 4-year follow-up studyAddiction, 2013
- Prospective association of childhood attention-deficit/hyperactivity disorder (ADHD) and substance use and abuse/dependence: A meta-analytic reviewClinical Psychology Review, 2011
- Efficacy of Methylphenidate for Adults with Attention-Deficit Hyperactivity DisorderCNS Drugs, 2011
- Comparing the efficacy of stimulants for ADHD in children and adolescents using meta-analysisEuropean Child & Adolescent Psychiatry, 2009
- Effect of Prior Stimulant Treatment for Attention-Deficit/Hyperactivity Disorder on Subsequent Risk for Cigarette Smoking and Alcohol and Drug Use Disorders in AdolescentsArchives of Pediatrics & Adolescent Medicine, 2008
- Age of Methylphenidate Treatment Initiation in Children With ADHD and Later Substance Abuse: Prospective Follow-Up Into AdulthoodAmerican Journal of Psychiatry, 2008